SupplementsProactive HealthWomens HealthLC40 BreastcareHereditum® LC40® Breastcare Clinical Studies

Hereditum® LC40® Breastcare Research Studies

LC40® Breastcare (Lactobacillus fermentum CECT5716) is the flagship clinically-backed probiotic from the Hereditum line that supports healthy breastfeeding.

LC40® offers an efficient alternative to the use of other ingredients during lactation.

Ultimately, LC40® helps to promote and maintain healthy breastfeeding and supports the health of new mothers throughout lactation.

Lactobacillus fermentum CECT 5716 Reduces Staphylococcus Load in the Breastmilk of Lactating Mothers Suffering Breast Pain: A Randomised Controlled Trial

Human mastitis and painful breastfeeding may be characterised by a mammary bacterial dysbiosis, a process in which the population of potential pathogens increases at the expense of the normal mammary microbiota. The study shows L. fermentum CECT5716 to be an efficient treatment for breast pain during lactation associated with a high level of Staphylococcus in breastmilk.

Study results show:

  • Significant decrease in the Staphylococcus load in the probiotic groups compared with the baseline loads (p=0.045).
  • Significant difference in the pain score was observed among the groups receiving the three probiotic doses compared with the control group.

Read study

 

Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomised Controlled Trial

This study evaluated the preventive effect of oral administration of Lactobacillus fermentum CECT5716 on mastitis incidence in lactating women. The oral administration of L. fermentum CECT5716 during lactation decreased by 51% the incidence rate of clinical mastitis. Staphylococcus spp. load at the end of intervention was significantly lower in breast milk of women in the probiotic group than in breast milk of women in the control group (p = 0.025).

Read Study

 

Treatment of Infectious Mastitis During Lactation: Antibiotics Versus Oral Administration of Lactobacilli Isolated from Breast Milk

In a study of the efficacy of oral administration of Lactobacillus fermentum CECT5716 or Lactobacillus salivarius CECT5713, two lactobacilli strains isolated from breast milk, to treat lactational mastitis were evaluated and compared with the efficacy of antibiotic therapy. Women assigned to the probiotic groups improved more and had lower recurrence of mastitis than those assigned to the antibiotic group.

Read Study

LET’S DRIVE IMPACT TOGETHER

We are here to be your most valued partner – to pioneer, problem-solve and bring better nutrition to billions. Through the ingenuity of our people, our groundbreaking technologies can influence real change in the world.

Not just for you, our customer – but for all people, society and the planet.

Get in touch

Contact us today to explore collaboration opportunities or to learn more about our solutions.

This website is intended to provide business-to-business information. The information and statements herein are for example only and products and claims may not be approved in your region. The information and statements herein must be reviewed for compliance with applicable local laws. Please check with your local account representative to inquire about market clearance and claims approved for your region.

Nothing in this web site is intended to be an offer which is capable of acceptance and/or inducement of any kind. Descriptions of, or references or access to other publications within the web site do not imply endorsement of those publications. This web site could contain technical inaccuracies, and changes to the information contained herein may be made at any time without notice.

Kerry Group P.L.C. (including its associate and subsidiary companies) neither makes nor gives any warranty of any kind with respect to any subject matter or information included in, or for the completeness or accuracy, of this web site. Kerry Group P.L.C. is not responsible for any actions (or lack thereof) taken as a result of relying on or in any way using information contained in this website and in no event shall it be liable for any damages resulting from reliance on or use for any purpose of this information. Without limiting the above, Kerry Group P.L.C. shall have no responsibility for any act or omission of any other contributor.